Market Insights Health OTC Pharmaceuticals

Analgesics - Colombia

Colombia

In Colombia, the revenue generated in the Analgesics market in 2024 amounts to €195.70m.
It is projected to experience an annual growth rate of 8.80% (CAGR 2024-2029).
When compared globally, the in the United States leads in revenue generation, with €6,716.00m in 2024.
On a per capita basis, in 2024, each person in Colombia generates revenues of €3.74.
Colombia's growing demand for OTC analgesics reflects a shift towards self-medication and a rising awareness of health and wellness.

Key regions: Brazil, Europe, Germany, Canada, United States

Mercado

Región

Comparación de regiones

Moneda

Analyst Opinion

The Analgesics market in Colombia is experiencing steady growth due to several factors. Customer preferences for pain relief medications, along with local special circumstances and underlying macroeconomic factors, contribute to the development of the market.

Customer preferences: Colombian customers have a strong preference for over-the-counter analgesics, such as acetaminophen and ibuprofen, due to their convenience and accessibility. These medications are widely available in pharmacies and supermarkets, allowing customers to easily purchase them without a prescription. Additionally, customers often prefer analgesics in tablet or capsule form, as they are easy to swallow and provide quick relief.

Trends in the market: One of the key trends in the Analgesics market in Colombia is the increasing demand for natural and herbal pain relief remedies. Customers are becoming more conscious about the potential side effects of traditional analgesics and are seeking alternative options. As a result, there has been a rise in the availability and popularity of natural analgesics, such as herbal supplements and topical creams made from plant extracts. This trend is driven by the growing health and wellness movement, as customers prioritize natural and holistic approaches to pain management.Another trend in the market is the rising demand for analgesics specifically formulated for certain types of pain, such as migraines or joint pain. Manufacturers are developing specialized analgesics that target specific pain symptoms, providing more targeted and effective relief. This trend is driven by the increasing awareness and understanding of different types of pain, as well as the desire for personalized healthcare solutions.

Local special circumstances: Colombia has a high prevalence of musculoskeletal disorders, such as arthritis and back pain, which contribute to the demand for analgesics. These conditions are often chronic and require long-term pain management, creating a consistent market for analgesics. Additionally, Colombia has a large aging population, which is more prone to developing chronic pain conditions. The increasing elderly population further drives the demand for analgesics in the country.

Underlying macroeconomic factors: Colombia's growing middle class and increasing disposable income levels have contributed to the development of the Analgesics market. As more people have the financial means to afford healthcare products, the demand for analgesics has increased. Additionally, the country's improving healthcare infrastructure and access to healthcare services have made analgesics more accessible to a larger population.In conclusion, the Analgesics market in Colombia is growing due to customer preferences for over-the-counter medications, the increasing demand for natural and specialized analgesics, local special circumstances such as a high prevalence of musculoskeletal disorders, and underlying macroeconomic factors such as a growing middle class and improving healthcare infrastructure. These factors collectively contribute to the development and expansion of the market in Colombia.

Methodology

Data coverage:

Data encompasses B2C spend. Figures are based on the OTC Pharmaceuticals market values, representing revenues generated by both product sales which take place exclusively in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use data from national statistical offices, international institutions, trade associations, and self-medication associations. Next, we use relevant key market indicators and data from country-specific associations, such as consumer healthcare spending, out-of-pocket healthcare expenditure, health system accessibilities, and GDP. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. Whereas this market covers only OTC drugs, the Statista Pharmaceuticals market covers both OTC and prescription drugs.